| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.7 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.01 | 0.7 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.7 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.8 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |